[ Price : $8.95]
Federal Register notice: FDA announces a 3/15 virtual meeting entitled FDA Hiring and Retention Final Assessment and an opportunit...[ Price : $8.95]
Federal Register notice: FDA debars Brian Michael Parks for five years from importing or offering for import any article of food (...[ Price : $8.95]
FDA takes issue with Denali Therapeutics preclinical toxicology assessment and requests changes to the clinical trial protocol, th...[ Price : $8.95]
FDA accepts for review a Spectrum Pharmaceuticals NDA for poziotinib and its use in treating patients with previously treated loca...[ Price : $8.95]
CDERs Office of Generic Drugs says it approved 100-designated Competitive Generic Therapy ANDAs in 2021 for products recognized as...[ Price : $8.95]
A pivotal Phase 2-3 trial (Illuminate) evaluating ProQR Therapeutics sepofarsen for treating genetic eye disease CEP290-mediated L...[ Price : $8.95]
FDA Review posts the Federal Register notices for the week ending 2/11/2022.[ Price : $8.95]
Federal Register notice: FDA classifies the spore test strip into medical device Class 2 (special controls).